Greenyn Biotechnology Co., Ltd (TPEX:6846)
44.90
-0.55 (-1.21%)
Nov 20, 2026, 1:18 PM CST
Greenyn Biotechnology Market Cap
Greenyn Biotechnology has a market cap or net worth of 1.21 billion as of November 20, 2026. It is the 31,795th most valuable company in the world and the 1,843rd biggest in Taiwan. Its market cap has decreased by 38.32% in one year.
Market Cap
1.21B
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#1,843 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since April 19, 2022, Greenyn Biotechnology's market cap has decreased from 2.03B to 1.21B, a decrease of -40.19%. That is a compound annual growth rate of -10.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 1.21B | -38.91% |
| Dec 31, 2025 | 1.98B | -8.66% |
| Dec 31, 2024 | 2.17B | 2.47% |
| Dec 29, 2023 | 2.12B | 6.41% |
| Dec 30, 2022 | 1.99B | -1.69% |
| Apr 19, 2022 | 2.03B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| U-Neuron Biomedical | 1.39B |
| GenMont Biotech Incorporation | 1.34B |
| Anti-Microbial Savior BioteQ | 1.34B |
| Synbio Tech | 1.33B |
| MegaPro Biomedical | 1.30B |
| NeoCore Technology | 1.20B |
| Advagene Biopharma | 1.19B |
| TaiRx | 1.18B |